Molecular structure and biological and pharmacological properties of 3- hydroxy-2-methyl-1-(β-D-ribofuranosyl or pyranosyl)-4-pyridinone: Potential iron overload drugs for oral administration

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 21, 1998, Pages 3077-3080

  Liu, Gang ^a   Bruenger, Fred W ^a   Miller, Scott C ^a   Arif, Aarif M ^b  

^a Radiobiology Division   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 2 METHYL 1 (BETA DEXTRO RIBOFURANOSYL) 4 PYRIDINONE; 3 HYDROXY 2 METHYL 1 (BETA DEXTRORIBOPYRANOSYL) 4 PYRIDINONE; FERRITIN; IRON CHELATE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG SYNTHESIS; HYDROGEN BOND; IRON CHELATION; IRON OVERLOAD; MOLECULAR INTERACTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TABLET FORMULATION; X RAY CRYSTALLOGRAPHY;

ADMINISTRATION, ORAL; FERRITINS; IRON CHELATING AGENTS; IRON OVERLOAD; PYRIDONES;

EID: 0032212588     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00569-1     Document Type: Article

References (19)

1. 1. World Health Organisation Community control of hereditary anaemias. WHO Bull. 1983, 61, 63.
2. 2. Iron and Human Disease; Lauffer, R. B., Ed.; CRC: Boca Raton, 1992.
3. 3. Weinberg, E. D. Physiol. Rev. 1984, 64, 65.
4. 4. Porter, J. Eur. J. Haematol. 1989, 43, 271.
5. 5. Kontoghiorghes, G. J. Toxicol. Lett. 1995, 80, 1.
6. 6. Kontoghiorghes, G. J.; Sheppard, L. Inorg. Chim. Acta 1987, 136, L11.
7. 7. Hider, R. C.; Singh, S.; Porter, J. B.; Huehns, E. R. Ann. N. Y. Acad. Sci. Bank, A., Ed.; New York Academy of Science, New York, 1990; 612, pp 327-338.
8. 8. Molenda, J. J.; Jones, M. M.; Basinger, M. A. J. Med. Chem. 1994, 37, 93.
9. 9. Porter, J. B.; Hayes, K. P.; Abeysinghe, R.; Huehns, E. R.; Hider, R. C. Lancet 1989, 156.
10. 10. Hider, R. C.; Porter, J. B.; Singh, S. The Development of Iron Chelators for Clinical Use; Bergeron, R. J.; Brittenham, G. M., Eds.; CRC: Boca Raton, 1994; pp 354-371.
11. 11. Liu, G.; Bruenger, F. W.; Barrios, A. M.; Miller, S. C. Nucleosides Nucleotides 1995, 14, 1901.
12. 3, Mo-Kα Radiation (0.71073 Å), No. of reflections measured: 1287, 2θ range: 4.00 to 50.00 Degree, Final refinement: R Factor = 0.0533, Weighted R Factor = 0.0633. Selected bond lengths (Å): C1-C2, 1.362 (7); C2-C3, 1.428 (7); C3-C4, 1.423 (7); C4-C5, 1.337 (7); N-C1, 1.383 (6); N-C5, 1.365 (6); N-C7, 1.463 (6). Selected angles(°): C1-N-C5, 120.1 (4); C1-N-C7, 121.4 (4); C5-N-C7, 118.5 (4); N-C1-C2, 118.8 (5); N-C1-C6, 120.5 (4); C2-C1-C6, 120.7 (5); O1-C2-C1, 117.7 (5); C1-C2-C3, 122.8 (5); O2-C3-C4, 124.2 (5); C2-C3-C4, 114.8 (5); C3-C4-C5, 121.4 (5); N-C5-C4, 122.0 (5); O3-C7-N, 106.9 (4); N-C7-C8, 113.0 (5). Atomic coordinates, bond lengths and bond angles have been deposited at the Cambridge Crystallographic Data Centre.
13. 13. Hider, R. C.; Taylor, P. D.; Walkinshaw, M.; Wang, J. L.; Van Der Helm, D. J. Chem. Res., Synop. 1990, 316.
14. 14. Nelson, W. O.; Karpishin, T. B.; Retting, S. J.; Orvig, C. Can. J. Chem. 1988, 66, 123.
15. 15. Dobbin, P. S.; Hider, R. C.; Hall, A. D.; Taylor, P. D.; Sarpong, P.; Porter, J. B.; Xiao, G.; Van Der Helm, D. J. Med. Chem. 1993, 36, 2448.
16. 16. O1-H1··O4 (2.762 Å (5), 144.0 ° (2)), O5-H11··O2 (2.676 Å (5), 150.6 ° (2)); O6-H13··O2 (2.707 Å (5), 142.2 ° (2)); O4-H9··O6 (2.708 Å (5), 148.7 ° (2)).
17. 17. Harris, D. C. Quantitative Chemical Analysis; W. H. Freeman and Company: New York, 1991; pp 523-524.
18. 19 The concentrations of the iron complex were determined spectrophotometrically from εmax values. The kinetics of iron release were investigated for periods up to 48 h.
19. 19. Kontoghiorghes, G. J. Biochem. J. 1986, 233, 299.